Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study

Journal of Lipid Research

Volumn 52, Issue 6, 2011, Pages 1181-1187

  Lamon Fava, Stefania ^a   Marcovina, Santica M ^b   Albers, John J ^b   Kennedy, Hal ^b   DeLuca, Carl ^a   White, Charles C ^c   Cupples, L Adrienne ^c   McNamara, Judith R ^a   Seman, Leo J ^a   Bongard, Vanina ^a   Schaefer, Ernst J ^a  

^a TUFTS UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c BOSTON UNIVERSITY   (United States)

Author keywords

Apolipoprotein; Cholesterol; Epidemiology; Triglycerides

Indexed keywords

APOLIPOPROTEIN A; LIPOPROTEIN A;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR;

APOLIPOPROTEINS A; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROGNOSIS; PROTEIN ISOFORMS; RISK FACTORS; TRIGLYCERIDES;

EID: 79955994340     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M012526     Document Type: Article

References (34)

1. Berg, K. 1963. A new serum type system in man: the Lp system. Acta Pathol. Microbiol. Scand. 59: 369-382.
2. Utermann, G., and W. Weber. 1983. Protein composition of Lp(a) lipoprotein from human plasma. FEBS Lett. 154: 357-361. (Pubitemid 13088374)
3. McLean, J. W., J. E. Tomlinson, W-J. Kuang, D. L. Eaton, E. Y. Chen, G. M. Fless, A. M. Scanu, and R. M. Lawn. 1987. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature. 330: 132-137.
4. Marcovina, S. M., H. H. Hobbs, and J. J. Albers. 1996. Relation between number of apolipoprotein(a) kringle 4 repeats and mobility of isoforms in agarose gel: basis for a standardized isoform nomenclature. Clin. Chem. 42: 436-439.
5. Utermann, G., H. J. Menzel, H. G. Kraft, H. C. Duba, H. G. Kemmler, and C. Seitz. 1987. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J. Clin. Invest. 80: 458-465.
6. Rader, D. J., W. Cain, K. Ikewaki, G. Talley, L. A. Zech, D. Usher, and H. B. Brewer. 1994. The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate. J. Clin. Invest. 93: 2758-2763.
7. Jenner, J. L., L. J. Seman, J. S. Millar, S. Lamon-Fava, F. K. Welty, G. G. Dolnikowski, S. M. Marcovina, A. H. Lichtenstein, P. H. Barrett, C. deLuca, et al. 2005. The metabolism of apolipoproteins (a) and B-100 within plasma Lipoprotein(a) in human beings. Metabolism. 54: 361-369.
8. Boerwinkle, E., C. G. Leffert, J. Lin, C. Lackner, G. Chiesa, and H. H. Hobbs. 1992. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J. Clin. Invest. 90: 52-60.
9. Clarke, R., J. F. Peden, J. C. Hopewell, T. Kyriakou, A. Goel, S. Heath, S. Parish, S. Barlera, M. G. Franzosi, and S. Rust, for the PROCARDIS Consortium. 2009. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N. Engl. J. Med. 361: 2518-2528.
10. Bennet, A., E. Di Angelantonio, S. Erqou, G. Eirikdottir, G. Sigurdsson, M. Woodward, A. Rumley, G. D. Lowe, J. Danesh, and V. Gudnason. 2008. Lipoprotein(a) levels and risk of future coronary heart disease. Arch. Intern. Med. 168: 598-608.
11. The Emerging Risk Factors Collaboration. 2009. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. J. Am. Med. Assoc. 302: 412-423.
12. Ignatescu, M., K. Kostner, G. Zorn, M. Kneussl, G. Maurer, I. M. Lang, and K. Huber. 1998. Plasma Lp(a) levels are increased in patients with chronic thromboembolic pulmonary hypertension. Thromb. Haemost. 80: 231-232.
13. Kang, C., M. Dominguez, S. Loyau, T. Miyata, V. Durlach, and E. Angles-Cano. 2002. Lp(a) particles mold fibrin-binding properties of apo(a) in size-dependent manner: a study with different-length recombinant apo(a), native Lp(a), and monoclonal antibody. Arterioscler. Thromb. Vasc. Biol. 22: 1232-1238.
14. Tsimikas, S., L. D. Tsironis, and A. D. Tselepis. 2007. New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 27: 2094-2099.
15. Feinleib, M., W. B. Kannel, P. M. McNamara, R. J. Garrison, and W. P. Castelli. 1975. The Framingham Offspring Study: design and preliminary data. Prev. Med. 4: 518-525.
16. Friedewald, W. T., R. I. Levy, and D. S. Fredrickson. 1972. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18: 499-502.
17. Marcovina, S. M., J. J. Albers, B. Gabel, M. L. Koschinsky, and V. P. Gaur. 1995. Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). Clin. Chem. 41: 246-255.
18. Dati F, JR Tate, S Marcovina, International Federation of Clinical Chemistry and Laboratory Medicine, IFCC Working Group for Lipoprotein(a) Assay Standardization. 2004. First WHO/IFCC international reference reagent for lipoprotein(a) for immunoassay- Lp(a) SRM 2B. Clin. Chem. Lab. Med. 42: 670-676.
19. Seman, L. J., J. L. Jenner, J. R. McNamara, and E. J. Schaefer. 1994. Quantification of lipoprotein(a) in plasma by assaying cholesterol in lectin-bound plasma fraction. Clin. Chem. 40: 400-403.
20. Gabriel, S. B., S. F. Schaffner, H. Nguyen, J. M. Moore, J. Roy, B. Blumenstiel, J. Higgins, M. DeFelice, A. Lochmenr, M. Faggart, et al. 2002. The structure of haplotype blocks in the human genome. Science. 296: 2225-2229. (Pubitemid 34680308)
21. Schaefer, E. J., S. Lamon-Fava, J. L. Jenner, J. R. McNamara, J. M. Ordovas, C. E. Davis, J. M. Abolafia, K. Lippel, and R. I. Levy. 1994. Lipoprotein(a) levels and risk of coronary heart disease in men. The Lipid Research Clinics Coronary Primary Prevention Trial. J. Am. Med. Assoc. 271: 999-1003.
22. Bostom, A. G., L. A. Cupples, J. L. Jenner, J. M. Ordovas, L. J. Seman, P. W. Wilson, E. J. Schaefer, and W. P. Castelli. 1996. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. J. Am. Med. Assoc. 276: 544-548.
23. Bostom, A. G., D. R. Gagnon, L. A. Cupples, P. W. Wilson, J. L. Jenner, J. M. Ordovas, E. J. Schaefer, and W. P. Castelli. 1994. A prospective investigation of elevated lipoprotein(a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study. Circulation. 90: 1688-1695.
24. Klausen, I. C., A. Sjol, P. S. Hansen, L. U. Gerdes, L. Moller, L. Lemming, M. Schroll, and O. Faegerman. 1997. Apolipoprotein(a) isoforms and coronary heart disease in men: a nested case-control study. Atherosclerosis. 132: 77-84. (Pubitemid 27306742)
25. Lundstam, U., J. Herlitz, T. Karlsson, T. Linden, and O. Wiklund. 2002. Serum lipids, lipoprotein(a), and apolipoprotein(a) isoforms as prognostic markers in patients with coronary heart disease. J. Intern. Med. 251: 111-118.
26. Kraft, H. G., A. Lingenhel, S. Kochl, F. Hoppichler, F. Kronenberg, A. Abe, V. Muhlberger, D. Schonitzer, and G. Utermann. 1996. Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 16: 713-719.
27. Katsouras, C. S., S. A. Karabina, A. P. Tambaki, J. A. Goudevenos, L. K. Michalis, L. D. Tsironis, C. S. Stroumbis, M. S. Elisaf, D. A. Sideris, and A. D. Tselepis. 2001. Serum lipoprotein(a) concentrations and apolipoprotein(a) isoforms: association with the severity of clinical presentation in patients with coronary heart disease. J. Cardiovasc. Risk. 8: 311-317.
28. Kamstrup, P. R., A. Tybjaerg-Hansen, R. Steffensen, and B. G. Nordestgaard. 2009. Genetically elevated lipoprotein(a) and increased risk of myocardial infaction. J. Am. Med. Assoc. 301: 2331-2339.
29. Rifai, N., J. Ma, F. M. Sacks, P. M. Ridker, W. J. L. Hernandez, M. J. Stampfer, and S. Marcovina. 2004. Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: The Physicians' Health Study. Clin. Chem. 50: 1364-1371.
30. Geethanjali, F. S., K. Luthra, A. Lingenhel, A. S. Kanagasaba-Pathy, J. Jacob, L. M. Srivastava, S. Vasisht, H. G. Kraft, and G. Utermann. 2003. Analysis of the apo(a) size polymorphism in Asian Indian populations: association with Lp(a) concentration and coronary heart disease. Atherosclerosis. 169: 121-130. (Pubitemid 36830930)
31. Wade, D. P., J. G. Clarke, G. E. Lindahl, A. C. Liu, B. R. Zysow, K. Meer, K. Schwartz, and R. M. Lawn. 1993. 5 ' Control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family. Proc. Natl. Acad. Sci. USA. 90: 1369-1373.
32. Luke, M. M., J. P. Kane, D. Liu, C. M. Rowland, D. Shiffman, J. Cassano, J. J. Catanese, C. R. Pullinger, D. U. Leong, A. R. Arellano, et al. 2007. A polymorphism in the protease-like domain of apolipoprotein(a) is associated with severe coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 27: 2030-2036.
33. Kiechl, S., J. Willeit, M. Mayr, B. Viehweider, M. Oberhollenzer, F. Kronenberg, C. J. Wiedermann, S. Oberthaler, Q. Xu, J. L. Witztum, et al. 2007. Oxidized phospholipids, lipoprotein(a), lipoproteinassociated phospholipase A2 activity, and 10-year cardiovascular outcomes. Prospective results from the Bruneck Study. Arterioscler. Thromb. Vasc. Biol. 27: 1788-1795.
34. Boffa, M. B., S. M. Marcovina, and M. L. Koschinsky. 2004. Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models. Clin. Biochem. 37: 333-343.